ACHIEVEMENT OF PASDAS LOW DISEASE ACTIVITY AND VERY LOW DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL OVER 4 YEARS AND THE OVERLAP WITH DAPSA AND MDA DISEASE ACTIVITY TARGETS

被引：0

作者：

Coates, Laura C. ^{[1
]}

Merola, Joseph F. ^{[2
]}

Fitzgerald, Oliver ^{[3
,4
]}

Kavanaugh, Arthur ^{[5
]}

Gottlieb, Alice B. ^{[6
]}

Tillett, William ^{[7
]}

Bauer, Lars ^{[8
]}

Hoepken, Bengt ^{[8
]}

Nurminen, Tommi ^{[8
]}

Mease, Philip J. ^{[9
,10
]}

Helliwell, Philip ^{[11
]}

van der Heijde, Desiree ^{[12
]}

机构：

[1] Nuffield Orthopaed Ctr, Oxford, England

[2] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA

[3] St Vincents Univ Hosp, Dublin, Ireland

[4] Univ Coll Dublin, Conway Inst Biomol Res, Dublin, Ireland

[5] UC San Diego Sch Med, Div Rheumatol Allergy & Immunol, La Jolla, CA USA

[6] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA

[7] Royal Natl Hosp Rheumat Dis, Bath, Avon, England

[8] UCB Pharma, Monheim, Germany

[9] Swedish Med Ctr, Seattle, WA USA

[10] Univ Washington, Seattle, WA 98195 USA

[11] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England

[12] Leiden Univ, Med Ctr, Leiden, Netherlands

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷

关键词：

D O I：

10.1136/annrheumdis-2019-eular.765

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

AB0742

引用

页码：1836 / 1837

页数：2

共 50 条

[31] MINIMAL DISEASE ACTIVITY IN PSORIATIC ARTHRITIS PREDICTS LOW IMPACT OF DISEASE
Kasavkar, Ganesh
Banerjee, Siwalik
Gullick, Nicola
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1274 - 1275
[32] Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis
Schoels, Monika
Aletaha, Daniel
Funovits, Julia
Kavanaugh, Arthur
Baker, Daniel
Smolen, Josef S.
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (08) : 1441 - 1447
[33] EFFECTS OF TREATMENT WITH RISANKIZUMAB ON MINIMAL DISEASE ACTIVITY (MDA) AND DISEASE ACTIVITY IN PSORIATIC ARTHRITIS (DAPSA): AN ANALYSIS OF THE KEEPSAKE-1 AND-2 TRIALS
Merola, J. F.
Mcinnes, I.
Kavanaugh, A.
Nash, P.
Xue, Z.
Stakias, V.
Eldred, A.
Ciecinski, S.
Douglas, K.
Coates, L.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 827 - 827
[34] THE IMPACT OF NUMBER OF COMORBIDITIES ON ACHIEVEMENT REMISSION OR LOW DISEASE ACTIVITY BY DAPSA IN PSORIATIC ARTHRITIS. DATA FROM THE RUSSIAN OBSERVATIONAL COHORT
Korsakova, Y.
Gubar, E.
Loginova, E.
Korotaeva, T.
Sorotskaya, V.
Patrikeeva, I.
Shesternya, P.
Umnova, I.
Nasonov, E.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 871 - 872
[35] Adipocytokines and achievement of low disease activity in rheumatoid arthritis
Baker, Joshua F.
England, Bryant R.
George, Michael D.
Wysham, Katherine
Johnson, Tate
Lenert, Aleksander
Kunkel, Gary
Sauer, Brian
Duryee, Michael J.
Monach, Paul
Kerr, Gail
Reimold, Andreas
Thiele, Geoffrey M.
Mikuls, Ted R.
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2022, 55
[36] Tapering and Discontinuation of Biologics in Patients with Psoriatic Arthritis with Low Disease Activity
Ye, Weiyu
Tucker, Laura J.
Coates, Laura C.
DRUGS, 2018, 78 (16) : 1705 - 1715
[37] Tapering and Discontinuation of Biologics in Patients with Psoriatic Arthritis with Low Disease Activity
Weiyu Ye
Laura J. Tucker
Laura C. Coates
Drugs, 2018, 78 : 1705 - 1715
[38] CHARACTERISATION OF DIFFERENT LOW DISEASE ACTIVITY MEASUREMENTS IN PATIENTS WITH PSORIATIC ARTHRITIS
Coates, L. C.
Gottlieb, A. B.
Merola, J. F.
Aikman, L.
Szumski, A.
Chhabra, A.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 947 - 948
[39] Psoriatic Arthritis Patients Who Attain a Very Low Disease Activity State Have a Minimal Impact of the Disease on Their Lives
Queiro, Ruben
Canete, Juan D.
Alberto Montilla-Morales, Carlos
Abad, Miguel A.
Gomez Castro, Susana
Cabez, Ana
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[40] PROBABILITY OF ACHIEVING LOW DISEASE ACTIVITY AT 52 WEEKS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH CERTOLIZUMAB PEGOL DEPENDS ON TIME TO AND LEVEL OF INITIAL RESPONSE
van der Heijde, Desiree
Schiff, Michael
Keystone, Edward
Landewe, Robert
Kvien, Tore
Curtis, Jeffrey
Khanna, Dinesh
Luijtens, Kristel
Furst, Dan
RHEUMATOLOGY, 2011, 50 : 116 - 117

← 1 2 3 4 5 →